Key publications are highlighted
Journals
Articles
Schrag A, Carroll C, Duncan G, Molloy S, Grover L, Hunter R, Brown R, Freemantle N, Whipps J & Serfaty MA (2022) 'Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson’s disease' BMC Neurology 22, (1) ,
DOI Open access
Stevens KN, Creanor S, Jeffery A, Whone A, Zajicek J, Foggo A, Jones B, Chapman R, Cocking L & Wilks J (2022) 'Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease' JAMA Neurology ,
DOI Open access
Rochester L & Carroll C (2022) 'Implications of research that excludes under-served populations' Nature Reviews Neurology 18, (8) 449-450 ,
DOI
Day JO, Smith S, Noyce AJ, Alty J, Jeffery A, Chapman R & Carroll C (2022) 'Challenges of Incorporating Digital Health Technology Outcomes in a Clinical Trial: Experiences from PD STAT' Journal of Parkinson's Disease 1-5 ,
DOI Open access
Kehagia AA, North TK, Grose J, Jeffery AN, Cocking L, Chapman R & Carroll C (2022) 'Enhancing Trial Delivery in Parkinson’s Disease: Qualitative Insights from PD STAT' Journal of Parkinson's Disease 1-14 ,
DOI Open access
Schofield C, Chaudhuri KR, Carroll C, Sharma JC, Pavese N, Evans J, Foltynie T, Reichmann H, Zurowska L & Soares-da-Silva P (2022) 'Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease' Neurodegenerative Disease Management 12, (2) 77-91 ,
DOI Open access
Masoli JAH, Down K, Nestor G, Hudson S, O’Brien JT, Williamson JD, Young CA & Carroll C (2021) 'A report from the NIHR UK working group on remote trial delivery for the COVID-19 pandemic and beyond' Trials 22, (1) ,
DOI Open access
Carroll C, Lees A, Reichmann H, Martins D, Magalhães D, Rocha J & Soares-Da-Silva P (2021) 'Influence of levodopa daily dose on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: Findings from the real-world OPTIPARK study' Journal of the Neurological Sciences 429, 119426-119426 ,
DOI
van Wamelen DJ, Sringean J, Trivedi D, Carroll CB, Schrag AE, Odin P, Antonini A, Bloem BR, Bhidayasiri R & Chaudhuri KR (2021) 'Digital health technology for non-motor symptoms in people with Parkinson's disease: Futile or future?' Parkinsonism and Related Disorders ,
DOI Open access
Jost ST, Visser-Vandewalle V, Rizos A, Loehrer PA, Silverdale M, Evans J, Samuel M, Petry-Schmelzer JN, Sauerbier A & Gronostay A (2021) 'Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease' Parkinson's Disease 7, (1) ,
DOI Open access
Vijiaratnam N, Girges C, Auld G, Chau M, Maclagan K, King A, Skene S, Chowdhury K, Hibbert S & Morris H (2021) 'Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The ‘Exenatide-PD3’ study' BMJ Open 11, (5) e047993-e047993 ,
DOI Open access
Eke CS, Jammeh E, Li X, Carroll C, Pearson S & Ifeachor E (2021) 'Early Detection of Alzheimer's Disease with Blood Plasma Proteins Using Support Vector Machines' IEEE Journal of Biomedical and Health Informatics 25, (1) 218-226 ,
DOI Open access
Witham MD, Anderson E, Carroll C, Dark PM, Down K, Hall AS, Knee J, Maher ER, Maier RH & Mountain GA (2020) 'Ensuring that COVID-19 Research is Inclusive - guidance from the NIHR INCLUDE project' BMJ Open 10, (11) ,
DOI Open access
Dominey T, Kehagia AA, Gorst T, Pearson E, Murphy F, King E & Carroll C (2020) 'Introducing the Parkinson’s KinetiGraph into Routine Parkinson’s Disease Care: A 3-Year Single Centre Experience' Journal of Parkinson's Disease 10, (4) 1827-1832 ,
DOI Open access
Witham MD, Anderson E, Carroll C, Dark PM, Down K, Hall AS, Knee J, Maier RH, Mountain GA & Nestor G (2020) 'Developing a roadmap to improve trial delivery for underserved groups: results from a UK multi-stakeholder process' Trials ,
DOI Open access
Richardson SJ, Carroll C, Close J, Gordon AL, O'Brien J, Quinn TJ, Rochester L, Sayer AA, Shenkin SD & van der Velde N (2020) 'Research with older people in a world with COVID-19: identification of current and future priorities, challenges and opportunities' Age and Ageing ,
DOI Open access
Edwards E & Carroll C (2020) 'In reply to: Helmich and Bloem (2020) “The Impact of the COVID-19 Pandemic on Parkinson’s Disease: Hidden Sorrows and Emerging Opportunities”' Journal of Parkinson's Disease 1-2 ,
DOI Open access
Barker RA, Bjorklund A, Gash DM, Whone A, Van Laar A, Kordower JH, Bankiewicz K, Kieburtz K, Saarma M & Booms S (2020) 'GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop' Journal of Parkinson's Disease 1-17 ,
DOI Open access
Zeissler M-L, Li V, Parmar MKB & Carroll CB (2020) 'Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson’s Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer' Journal of Parkinson's Disease 10, (2) 413-428 ,
DOI Open access
Kelly J, Moyeed R, Carroll C, Luo S & Li X (2020) 'Genetic networks in Parkinson’s and Alzheimer’s disease' Aging ,
DOI Open access
Reichmann H, Lees A, Rocha J-F, Magalhães D & Soares-da-Silva P (2020) 'Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study' Translational Neurodegeneration 9, (1) ,
DOI Open access
Williams NM, Hubbard L, Sandor C, Webber C, Hendry H, Carroll C, Lawton M, Chaudhuri KR, Morris H & Hu MT (2020) 'Genome-wide association study of pain in Parkinson's disease implicates TRPM8 as a risk factor' Movement Disorders ,
DOI Open access
Soundy A, Collett J, Lawrie S, Coe S, Roberts H, Hu M, Bromley S, Harling P, Reed A & Coeberg J (2019) 'A qualitative study on the impact of First Steps- a peer-led, educational intervention for people newly diagnosed with Parkinson’s Disease' Behavioral Sciences ,
DOI Open access
Carroll C, Webb D, Stevens ??? KN, Vickery J, Eyre V, Ball S, Wyse R, Webber M, Foggo A & Zajicek J (2019) 'Simvastatin as a neuroprotective treatment for Parkinson’s disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study' BMJ Open ,
DOI Open access
Carroll C, Kobylecki C, Silverdale M & Thomas C (2019) 'Impact of Quantitative Assessment of Parkinson’s Disease-Associated Symptoms Using Wearable Technology on Treatment Decisions' Journal of Parkinson's Disease 9, (3) 601-601 ,
DOI Open access
Carroll CB, Wyse RKH & Grosset DG (2019) 'Statins and Parkinson's: A complex interaction' Movement Disorders 34, (7) 934-935 ,
DOI Open access
Trivedi DK, Sinclair E, Xu Y, Sarkar D, Walton-Doyle C, Liscio C, Banks P, Milne J, Silverdale M & Kunath T (2019) 'Discovery of Volatile Biomarkers of Parkinson’s Disease from Sebum' ACS Central Science 5, (4) 599-606 ,
DOI Open access
Kelly J, Moyeed R, Carroll C, Albani D & Li X (2019) 'Gene expression meta-analysis of Parkinson's disease and its relationship with Alzheimer's disease' Molecular Brain 12, (1) 0-0 ,
DOI Open access
Martinez-Martin P, Rizos AM, Wetmore JB, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D & Falup-Pecurariu C (2018) 'Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease' Movement Disorders Clinical Practice ,
DOI Open access
Carroll CB, Fackrell R, Grosset D, Mohamed B, Reddy P, Parry M, Chaudhuri K & Foltynie T (2018) 'Noninvasive options for ‘wearing-off’ in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialists' Neurodegenerative Disease Management Open access
Eke CS, Jammeh E, Li X, Carroll C, Pearson S & Ifeachor E (2018) 'Identification of Optimum Panel of Blood-based Biomarkers for Alzheimer’s Disease Diagnosis Using Machine Learning' 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) ,
DOI Open access
Jammeh EA, Carroll CB, Pearson SW, Escudero J, Anastasiou A, Zhao P, Chenore T, Zajicek J & Ifeachor E (2018) 'Machine-learning based identification of undiagnosed dementia in primary care: a feasibility study' BJGP Open 2, (2) 0-0 ,
DOI Open access
Ramaswamy B, Jones J & Carroll C (2018) 'Exercise for people with Parkinson’s: a practical approach' Practical Neurology 18, (5) ,
DOI Open access
Martinez-Martin P, Rizos AM, Wetmore J, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D & Falup-Pecurariu C (2018) 'First comprehensive tool for screening pain in Parkinson's disease: The King's Parkinson's Disease Pain Questionnaire (KPPQ)' European Journal of Neurology 25, (10) 1255-1261 Author Site ,
DOI Open access
Carroll CB & Wyse RKH (2017) 'Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson’s Disease: Rationale for Clinical Trial, and Current Progress' Journal of Parkinson's Disease ,
DOI Open access
Lubbe SJ, Escott-Price V, Brice A, Gasser T, Pittman AM, Bras J, Hardy J, Heutink P, Wood NM & Singleton AB (2016) 'Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease' Neurobiology of Aging 48, 222.e1-222.e7 ,
DOI Open access
Jammeh E, Zhao P, Carroll C, Pearson S & Ifeachor E (2016) 'Identification of blood biomarkers for use in point of care diagnosis tool for Alzheimer's disease' 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) ,
DOI Open access
Jammeh E, Zhao P, Carroll C, Pearson S & Ifeachor E (2016) 'Identification of blood biomarkers for use in point of care diagnosis tool for Alzheimer's disease' Annu Int Conf IEEE Eng Med Biol Soc 2016, 2415-2418 Author Site ,
DOI
Zeissler M-L, Eastwood J, McCorry K, Hanemann OC, Zajicek JP & Carroll CB (2016) 'Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis' Oncotarget ,
DOI Open access
Rizos A, Martinez-Martin P, Pal S, Carroll C, Martino D, Sophia R, Falup-Pecurariu C, Kessel B, Sauerbier A & Martin A (2016) 'The First Parkinson's Disease Pain Questionnaire (King's PD Pain Quest) – an interim analysis of a multicentre study of the patient's perspective' Parkinsonism & Related Disorders 22, e41-e41 ,
DOI
Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, Carroll C, Paviour D, Falup-Pecurariu C & Kessel B (2015) 'King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation' Movement Disorders 30, (12) 1623-1631 ,
DOI Open access
Kamel Boulos MN, Ifeachor E, Escudero Rodriguez J, Zhao P, Carroll CB, Costa P, Doppler G, Carrasco L, Spiru L & Helga K (2015) 'LiveWell - Promoting Healthy Living and Wellbeing for Parkinson Patients Through Social Network and ICT Training: Lessons Learnt and Best Practices' International Journal of Healthcare Information Systems and Informatics
Cooke T, Carroll C, Zajicek J, Ellard S & Morrison K (2013) 'Molecular genetic studies of neurodegenerative disease' J Neurol Neurosurg Psychiatry 84, (11) Author Site ,
DOI Open access
Zeissler ML, Eastwood J, Oliver Hanemann C, Zajicek J & Carroll C (2013) 'Δ9-TETRAHYDROCANNABINOL IS PROTECTIVE THROUGH PPARγ DEPENDENT MITOCHONDRIAL BIOGENESIS IN A CELL CULTURE MODEL OF PARKINSON'S DISEASE' J Neurol Neurosurg Psychiatry 84, (11) Author Site ,
DOI Open access
Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, Broughton E, Hagan H & Carroll C (2013) 'Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease' Acta Neuropathologica 1-7 Author Site ,
DOI
Ammoun S, Schmid MC, Ristic N, Zhou L, Hilton D, Ercolano E, Carroll C & Hanemann CO (2012) 'The role of insulin-like growth factors signaling in merlin-deficient human schwannomas' Glia 60, (11) 1721-1733 Author Site ,
DOI Open access
Carroll CB, Zeissler M-L, Hanemann CO & Zajicek JP (2012) 'Δ<sup>9</sup>-tetrahydrocannabinol (Δ<sup>9</sup>-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease' Neuropathology and Applied Neurobiology 38, (6) 535-547 ,
DOI
Carroll C, Palmer A, Cosby C & Zajicek J (2012) 'Analysis and validation of a Parkinson's disease register as a recruitment tool for clinical studies' Clin Med (Lond) 12, (3) 210-215 Author Site ,
DOI Open access
Carroll CB, Palmer A, Cosby C & Zajicek JP (2011) 'Analysis and validation of a Parkinson's disease register as a recruitment tool for clinical studies' Trials 12 Suppl 1, ,
DOI
Carroll CB, Zeissler M-L, Chadborn N, Gibson K, Williams G, Zajicek JP, Morrison KE & Hanemann CO (2011) 'Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson's disease' Neurochem Int 59, (1) 73-80 Author Site ,
DOI Open access
Carroll CB & Zajicek JP (2011) 'Designing clinical trials in older people' Maturitas 68, (4) 337-341 Author Site ,
DOI Open access
Carroll C, Krolikowski K, Mukonoweshuro W, Jones J & Hanemann CO (2010) 'Unilateral cerebral hemisphere oedema as a peri-ictal phenomenon' J Neurol 257, (12) 2094-2096 Author Site ,
DOI
Carroll CB, Zeissler ML, Stone V, Hanemann CO & Zajicek JP (2010) 'Cannabinoids Are Neuroprotective in a Human Cell Culture Model of Parkinson's Disease' MOVEMENT DISORDERS 25, S621-S621 Author Site Open access
Carroll CB, Zeissler ML, Chadborn N, Gibson K, Williams GJ, Morrison KE, Zajicek JP & Hanemann CO (2010) 'Changes in Iron-Regulatory Gene Expression Occur in Human Cell Culture Models of PD' MOVEMENT DISORDERS 25, S628-S628 Author Site Open access
Zeissler, Carroll CB & Zajicek J (2010) 'CBD & D9-THC - the two faces of cannabis' Cell Science 7, (1) Open access
Sinclair AJ, Carroll C & Davies B (2009) 'Cauda equina syndrome following a lumbar puncture' J Clin Neurosci 16, (5) 714-716 Author Site ,
DOI Open access
Katzenschlager R, Schrag A, Evans A, Manson A, Carroll CB, Ottaviani D, Lees AJ & Hobart J (2007) 'Quantifying the impact of dyskinesias in PD: the PDYS-26: a patient-based outcome measure' Neurology 69, (6) 555-563 Author Site ,
DOI
Carroll CB, Tengah DSNAP, Lawthom C & Venables G (2007) 'The feminisation of British neurology: implications for workforce planning' Clin Med (Lond) 7, (4) 339-342 Author Site ,
DOI Open access
Goodall EF, Greenway MJ, van Marion I, Carroll CB, Hardiman O & Morrison KE (2005) 'Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS' Neurology 65, (6) 934-937 Author Site ,
DOI
Liu XG, Carroll CB, Wang SY, Zajicek J & Bain PG (2005) 'Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasks' JOURNAL OF NEUROSCIENCE METHODS 144, (1) 47-52 Author Site ,
DOI Open access
Carroll CB, Hilton DA, Hamon M & Zajicek JP (2005) 'Muscle cramps and weakness secondary to graft versus host disease fasciitis' Eur J Neurol 12, (4) 320-322 Author Site ,
DOI Open access
McSherry JW, Carroll CB, Zajicek J, Teare L & Bain P (2005) 'Cannabis for dyskinesia in Parkinson disease: A randomized double-blind crossover study' Neurology 64, (6) 1100-1100 ,
DOI
Carroll CB, Bain PG, Teare L, Liu X, Joint C, Wroath C, Parkin SG, Fox P, Wright D & Hobart J (2004) 'Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study' Neurology 63, (7) 1245-1250 Author Site ,
DOI
Carroll CB & Zajicek JP (2004) 'The 'harlequin' sign in association with multiple sclerosis' JOURNAL OF NEUROLOGY 251, (9) 1145-1146 Author Site ,
DOI
Carroll CB & Bain PG (2004) 'Do on-off variations cause discrepancies in the historical items of the UPDRS?' MOVEMENT DISORDERS 19, (5) 605-605 Author Site ,
DOI Open access
Fox P, Bain PG, Glickman S, Carroll C & Zajicek J (2004) 'The effect of cannabis on tremor in patients with multiple sclerosis' Neurology 62, (7) 1105-1109 Author Site ,
DOI
Carroll C, Hobart J, Fox C, Teare L & Gibson J (2004) 'Stroke in Devon: knowledge was good, but action was poor' J Neurol Neurosurg Psychiatry 75, (4) 567-571 Author Site ,
DOI Open access
Carroll C & Zajicek J (2004) 'Provision of 24 hour acute neurology care by neurologists: manpower requirements in the UK' J Neurol Neurosurg Psychiatry 75, (3) 406-409 Author Site ,
DOI Open access
Carroll CB & Gardner-Thorpe C (2004) 'Charles Karsner Mills (1845-1931) and his syndrome' Some Aspects of History of Neuroscience 35-36
Hadjikoutis S, Carroll CB & Plant GTP (2004) 'Raised intracranial pressure presenting with spontaneous periorbital bruising: two case reports' Journal of Neurology, Neurosurgery and Psychiatry 75, (8) Open access
Weeks RA, Scaravilli F, Lees AJ, Carroll CB, Husain M & Rudge P (2002) 'Cerebral amyloid angiopathy and motor neurone disease presenting with a progressive supranuclear palsy-like syndrome' Movement Disorders 18, (3)
Faccenda KA & Finucane BT (2001) 'Complications of Regional Anaesthesia' Drug Safety 24, (6) 413-442 ,
DOI
Cooper AJ, Carroll CB & Mitchell IJ (1998) 'Glutamate antagonists for Parkinson's disease - Rationale for use and therapeutic implications' CNS DRUGS 9, (6) 421-429 Author Site ,
DOI
Scott R (1998) 'Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures' Brain 121, (4) 659-675 ,
DOI
Carroll CB, Scott R, Davies LE & Aziz T (1998) 'The pallidotomy debate' British Journal of Neurosurgery 2, (12)
B. CARROLL C, SCOTT R, DAVIES LE & AZIZ T (1998) 'The pallidotomy debate' British Journal of Neurosurgery 12, (2) 146-150 ,
DOI
Biousse V, Newman NJ, Carroll CB, Mewes K, Vitek JL, Bakay RAE, Baron MS & DeLong MR (1998) 'Visual fields in patients with posterior GPi pallidotomy'
Mitchell IJ & Carroll CB (1997) 'Reversal of parkinsonian symptoms in primates by antagonism of excitatory amino acid transmission: potential mechanisms of action' Neurosci Biobehav Rev 21, (4) 469-475 Author Site ,
DOI Open access
MITCHELL IJ, HUGHES N, CARROLL CB & BROTCHIE JM (1995) 'REVERSAL OF PARKINSONIAN SYMPTOMS BY INTRASTRIATAL AND SYSTEMIC MANIPULATIONS OF EXCITATORY AMINO-ACID AND DOPAMINE TRANSMISSION IN THE BILATERAL 6-OHDA LESIONED MARMOSET' BEHAVIOURAL PHARMACOLOGY 6, (5-6) 492-507 Author Site
CARROLL CB, HOLLOWAY V, BROTCHIE JM & MITCHELL IJ (1995) 'NEUROCHEMICAL AND BEHAVIORAL INVESTIGATIONS OF THE NMDA RECEPTOR-ASSOCIATED GLYCINE SITE IN THE RAT STRIATUM - FUNCTIONAL IMPLICATIONS FOR TREATMENT OF PARKINSONIAN SYMPTOMS' PSYCHOPHARMACOLOGY 119, (1) 55-65 Author Site ,
DOI
Brotchie JM, Crossman ARC, Mitchell IJ, Duty S, Carroll CB, Cooper AJC, Henry B, Hughes N & Maneuf Y (1993) 'Chemical signalling in the globus pallidus in parkinsonism' Progress in Brain Research (99) 125-139
Carroll C 'Implications of research that excludes under-served populations' Nature Reviews Neurology ,
DOI
Conference Papers
Aldred J, Amelin A, Antonini A, Bergmans B, Bergquist F, Bouchard M, Budur K, Carroll C, Chaudhuri K & Criswell S (2022) 'Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Results From a 12-Month Phase 3 Study' 178-179
Isaacson S, Di Lorenzo G, Facheris M, Fung V, Henriksen T, Ikenaka K, Jia J, Kern D, Kukreja P & Santos Garcia D (2022) 'Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Results by Age, Disease Duration, and Baseline "Off" Time' 444-445
Mueller M, Cosman J, Adams JL, Badawy R, Bhatnagar R, Bloem B, Carroll C, Cooray N, Dam T & Dexter DT (2022) 'Interaction with Regulatory Agencies Worldwide to Advance the Use of Digital Health Technology in Parkinson's Disease Clinical Research: the Critical Path for Parkinson's Pre-Competitive 3DT Initiative' S21-S22
Carroll C, Lees A, Ferreira J, Fonseca M, Magalhães D, Rocha J & Soares-Da-Silva P (2021) 'Impact of 3-month earlier versus later initiation of opicapone versus entacapone in levodopa-treated patients with Parkinson's disease and motor fluctuations' Elsevier BV 119447-119447 ,
DOI
Carroll C, Lees A, Ferreira J, Fonseca M, Magalhaes D, Rocha J-F & Soares-da-Silva P (2021) 'Impact of 3-month early versus postponed initiation of opicapone vs entacapone in Parkinson's levodopa-treated patients' 626-627
Carroll C, Lees A, Reichmann H, Martins D, Magalhaes D, Rocha J & Soares-da-Silva P (2021) 'Influence of levodopa daily dose in Opicapone effectiveness in Parkinson's: the real-world OPTIPARK study' 275-275
Gorst T, Dominey T, Whipps J, Whipps S, Cooke J, Mullin S, Maramba I, Edwards E & Carroll C (2020) 'Not so simple: the challenge of developing a non-motor symptoms app (NMS Assist) for people with Parkinson's (PwP)' S652-S652 Open access
Dominey T, Mullin S, Edwards E, Whipps J, Whipps S & Carroll C (2019) 'USABILITY TESTING OF A NON-MOTOR SYMPTOM APP IN PD' E47-E47 ,
DOI Open access
Pujara P, Rideout J & Carroll C (2016) 'IMPROVING PROVISION OF PARKINSON'S DISEASE EXERCISE CLASSES' BMJ e1.14-e1 ,
DOI
Blight B, Davis J, Evans V, Hawkes N & Carroll C (2016) 'IMPROVING THE EXPERIENCE OF DIAGNOSIS IN PARKINSON'S DISEASE' BMJ e1.234-e1 ,
DOI
Dominey T, Newman C, Carroll C, Noad R, Appleyard B, Deeprose C & Hall S (2016) 'PD-TAP: AN OBJECTIVE AND AUTOMATED MEASURE OF PARKINSON'S DISEASE SEVERITY' BMJ e1.237-e1 ,
DOI
Stamford J, Isaacs T & Carroll C (2015) 'People with Parkinson's design clinical trials charter to improve communication about, recruitment to and retention in Parkinson's clinical trials' Springer Science and Business Media LLC ,
DOI
Creanor S, Vickery J, Eyre V, Zajicek J, Ball S, Elm J & Carroll C (2015) 'Two-arm randomised futility trials: PD-stat - a futility trial of a potential neuroprotective treatment in people with Parkinson's disease' Springer Science and Business Media LLC ,
DOI
Noad R, Newman C, Carroll C & Zajicek J (2015) 'iPAD-BASED ASSESSMENT IN PARKINSON'S DISEASE' BMJ e4.189-e4 ,
DOI
Koopman H, Jackson S, Anichtchik O & Carroll C (2015) 'LPS INDUCES AGGREGATION OF α-SYNUCLEIN IN MONOCYTES' BMJ e4.188-e4 ,
DOI
Jammeh E, Carroll C, Pearson S, Escudero J, Anastasiou A, Zajicek J & Ifeachor E (2015) 'USING NHS PRIMARY CARE DATA TO IDENTIFY UNDIAGNOSED DEMENTIA' BMJ e4.134-e4 ,
DOI
Hilton DA, Stephens M, Zajicek J, Broughton E, Hagan H, Edwards P & Carroll C (2013) 'Accumulation of alpha synuclein in the bowel in preclinical Parkinson's disease' 11-11
Hilton DA, Zeissler ML, Zhang H, Zajicek J, Hicks J, Eastwood J & Carroll C (2013) 'Cannabinoid receptor expression in Parkinson's disease' 34-35
Salter E, Zeissler ML, Alexander SPH, Hanemann CO, Zajicek JP & Carroll CB (2012) 'ENDOCANNABINOID TOXICITY IN A CELL CULTURE MODEL OF PARKINSON'S DISEASE' BMJ A13.4-A14 ,
DOI
Zeissler M, Hanemann CO, Zajicek JP & Carroll CB (2012) 'FAAH INHIBITION IS PROTECTIVE IN A CELL CULTURE MODEL OF PARKINSON'S DISEASE' ,
DOI
Zeissler ML, Hanemann O, Zajicek JP & Carroll CB (2012) 'Delta(9)-THC is protective in a cell culture model of Parkinson's disease through a PPAR gamma mediated mechanism resulting in increased expression of PGC1-alpha' S39-S39
Zeissler M, Carroll CB, Hanemann CO & Zajieck JP (2012) '108 Investigating the neuroprotective properties of Δ9-THC in a cell culture model of Parkinson's disease' BMJ e1.58-e1 ,
DOI
Carroll C, Zajicek JP, Hanemann CO, Stone V & Zeissler M (2010) 'CANNABINOIDS ARE NEUROPROTECTIVE IN A HUMAN CELL CULTURE MODEL OF PARKINSON'S DISEASE' E60-E60 ,
DOI
Carroll C, Williams GJ, Chadborn NH, Hanemann CO, Zajicek JP, Morrison KE, Gibson K & Zeissler M (2010) 'CHANGES IN IRON-REGULATORY GENE EXPRESSION OCCUR IN HUMAN CELL CULTURE MODELS OF PARKINSON'S DISEASE' E29-E29 ,
DOI
Carroll CB, Chadborn N, Hanemann O & Zajicek J (2009) 'CANNABINOIDS ARE NEUROPROTECTIVE IN A CELL CULTURE MODEL OF PARKINSON'S DISEASE' ,
DOI
Sinclair AJ, Carroll C & Davies MB (2007) 'A rare complication of a common procedure: Acute cauda equina syndrome following a lumbar puncture' 218-218
Carroll CB, Majumdar D, Winer JB & Davies NP (2005) 'Childhood onset demyelinating neuropathy and cataracts: A potentially treatable disorder' 1323-1324
Carroll CB & Zajicek JP (2005) 'Clinical viral encephalitis in adults: A 10 year retrospective study' 157-158
Carroll CB & Zajicek JZ (2003) 'Meeting the Association of British Neurologists guidelines: Provision of 24 hour acute neurology care by neurologists' 1453-1453
Carroll C, Hobart J, Fox C, Teare L & Gibson J (2003) 'Stroke in Devon: The need to translate knowledge into action' 1176-1177
Carroll C & Gardner-Thorpe C (2003) 'Charles Karsner Mills (1845-1931) and his syndrome' 406-406